Pathogenesis of the antiphospholipid syndrome revisited: time to challenge the dogma

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203 · see citing works

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).

McNeil, H. P., Simpson, R. J., Chesterman, C. N., & Krilis, S. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4120 · Cited by 1,595 · see citing works

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

Galli, M., Barbui, T., Comfurius, P., Maassen, C., Hemker, H. C., Zwaal, R. F. A., Bevers, E. M., Baets, M. H. D., & Vriesman, P. J. C. V. B. (1990) · The Lancet · doi:10.1016/0140-6736(90)91374-j · Cited by 1,266 · see citing works

Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature

Galli, M., Luciani, D., Bertolini, G., & Barbui, T. (2003) · Blood · doi:10.1182/blood-2002-02-0441 · Cited by 974 · see citing works

The Pathogenesis of the Antiphospholipid Syndrome

Giannakopoulos, B., & Krilis, S. A. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1112830 · Cited by 682 · see citing works

Heparin prevents antiphospholipid antibody–induced fetal loss by inhibiting complement activation

Girardi, G., Redecha, P. B., & Salmon, J. E. (2004) · Nature Medicine · doi:10.1038/nm1121 · Cited by 680 · see citing works

Pathogenesis of antiphospholipid syndrome: understanding the antibodies

Meroni, P. L., Borghi, M. O., Raschi, E., & Tedesco, F. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.52 · Cited by 620 · see citing works

Anti–β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome

Galli, M., Luciani, D., Bertolini, G., & Barbui, T. (2003) · Blood · doi:10.1182/blood-2002-11-3334 · Cited by 413 · see citing works

Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor

Matsuura, E., Igarashi, Y., Fujimoto, M., Ichikawa, K., Suzuki, T., Sumida, T., Yasuda, T., & Koike, T. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.12.3885 · Cited by 322 · see citing works

Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis

Reynaud, Q., Lega, J.-C., Mismetti, P., Chapelle, C., Wahl, D., Cathébras, P., & Laporte, S. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.11.004 · Cited by 179 · see citing works

β2-glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model

Arad, A., Proulle, V., Furie, R. A., Furie, B. C., & Furie, B. (2011) · Blood · doi:10.1182/blood-2010-08-300715 · Cited by 140 · see citing works

Antiphospholipid syndrome: antibodies to Domain 1 of β2‐glycoprotein 1 correctly classify patients at risk

Pengo, V., Ruffatti, A., Tonello, M., Cuffaro, S., Banzato, A., Bison, E., Denas, G., & Padayattil Jose, S. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12865 · Cited by 126 · see citing works

Thrombogenic Properties of Murine Anti-Cardiolipin Antibodies Induced by β 2 Glycoprotein 1 and Human Immunoglobulin G Antiphospholipid Antibodies

Pierangeli, S. S., Liu, X. W., Anderson, G., Barker, J. H., & Harris, E. N. (1996) · Circulation · doi:10.1161/01.cir.94.7.1746 · Cited by 118 · see citing works

Antiphospholipid antibodies induce translocation of TLR7 and TLR8 to the endosome in human monocytes and plasmacytoid dendritic cells

Prinz, N., Clemens, N., Strand, D. J., Pütz, I., Lorenz, M., Daiber, A., Stein, P., Degreif, A., Radsak, M. P., Schild, H., et al. (2011) · Blood · doi:10.1182/blood-2011-01-330639 · Cited by 115 · see citing works

Functional Analyses of Patient-derived IgG Monoclonal Anticardiolipin Antibodies Using In Vivo Thrombosis and In Vivo Microcirculation Models

Pierangeli, S. S., Liu, X., Espinola, R. G., Olee, T., Zhu, M., Harris, N., & Chen, P. P. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1607384 · Cited by 100 · see citing works

β2‐glycoprotein 1 (β2GP1) enhances cardiolipin binding activity but is not the antigen for antiphospholipid antibodies

Pierangeli, S. S., Harris, E. N., Davis, S. A., et al. (1992) · British Journal of Haematology · doi:10.1111/j.1365-2141.1992.tb06468.x · Cited by 87 · see citing works

Reactivity to beta 2 glycoprotein I clearly differentiates anticardiolipin antibodies from antiphospholipid syndrome and syphilis.

Forastiero, R. R., Martinuzzo, M. E., Kordich, L., & Carreras, L. O. (1996) · PubMed · Cited by 84 · see citing works

dRVVT Is more Sensitive than KCT or TTI for Detecting Lupus Anticoagulant Activity of Anti-β2-glycoprotein I Autoantibodies

Biasiolo, A., Rampazzo, P., Brocco, T., & Pengo, V. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614453 · Cited by 76 · see citing works

Antibodies to Domain I of β2Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)

Banzato, A., Pozzi, N., Frasson, R., Filippis, V. D., Ruffatti, A., Bison, E., Jose, S. P., Denas, G., & Pengo, V. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.04.021 · Cited by 73 · see citing works

Reactivity to β2 Glycoprotein I Clearly Differentiates Anticardiolipin Antibodies from Antiphospholipid Syndrome and Syphilis

Forastiero, R. R., Martinuzzo, M. E., Kordich, L., & Carreras, L. O. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650354 · Cited by 72 · see citing works

A two‐step coagulation test to identify antiβ2‐glycoprotein I lupus anticoagulants

Pengo, V., Biasiolo, A., Pegoraro, C., & Iliceto, S. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00712.x · Cited by 70 · see citing works

Cofactor-independent antiphospholipid antibodies activate the NLRP3-inflammasome via endosomal NADPH-oxidase: implications for the antiphospholipid syndrome

Müller‐Calleja, N., Köhler, A., Siebald, B., Canisius, A., Orning, C., Radsak, M. P., Stein, P., Mönnikes, R., & Lackner, K. J. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-07-0628 · Cited by 66 · see citing works

Cofactor‐independent human antiphospholipid antibodies induce venous thrombosis in mice

Manukyan, D., Müller‐Calleja, N., Jäckel, S., Luchmann, K., Mönnikes, R., Kiouptsi, K., Reinhardt, C., Jurk, K., Walter, U., & Lackner, K. J. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13263 · Cited by 58 · see citing works

Endosomal NADPH-oxidase is critical for induction of the tissue factor gene in monocytes and endothelial cells

Prinz, N., Clemens, N., Canisius, A., & Lackner, K. J. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-06-0421 · Cited by 53 · see citing works

Isolation and Characterization of Two Human Monoclonal Anti-Phospholipid IgG from Patients with Autoimmune Disease

von Landenberg, C., Lackner, K. J., von Landenberg, P., et al. (1999) · Journal of Autoimmunity · doi:10.1006/jaut.1999.0316 · Cited by 48 · see citing works

A systematic analysis of sequences of human antiphospholipid and anti–β2-glycoprotein I antibodies: The importance of somatic mutations and certain sequence motifs

Giles, I., Haley, J., Nagl, S., Isenberg, D. A., Latchman, D. S., & Rahman, A. (2003) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2003.49994 · Cited by 43 · see citing works

Receptors involved in cell activation by antiphospholipid antibodies

Brandt, K. J., Kruithof, E. K. O., & de Moerloose, P. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.08.015 · Cited by 36 · see citing works

From antibody to clinical phenotype, the black box of the antiphospholipid syndrome: Pathogenic mechanisms of the antiphospholipid syndrome

Du, V. X., Kelchtermans, H., de Groot, P. G., & de Laat, B. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.07.023 · Cited by 35 · see citing works

An adapted ELISA method for differentiating pathogenic from nonpathogenic aPL by a beta 2 glycoprotein I dependency anticardiolipin assay

Levy, R. A., de Meis, E., & Pierangeli, S. S. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.06.032 · Cited by 28 · see citing works

Pathogenesis of the antiphospholipid syndrome revisited: time to challenge the dogma: comment

Pengo, V. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13510 · Cited by 2 · see citing works

Untitled work

(1998) · doi:10.1002/1529-0131(199806)41:6

Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant

Posch, F., Gebhart, J., Rand, J. H., Koder, S., Quehenberger, P., Pengo, V., Ay, C., & Pabinger, I. (2017) · BMC Medicine · doi:10.1186/s12916-017-0807-7 · Cited by 25 · see citing works

Late pregnancy complications in systemic lupus erythematosus and antiphospholipid syndrome.

Lakasing, L., & Khamashta, M. (1998) · PubMed

Pathogenesis and Pathophysiology of Nasal Polyps

Tos, M., Larsen, P. L., Larsen, K., et al. (2010) · Springer eBooks · doi:10.1007/978-3-642-11412-0_7 · Cited by 7 · see citing works

Research Progresses in Pathophysiological Roles of Urotensin II in Plasma of Bronchial Asthma Patients

Shu-la, L. (2009) · Medical Recapitulate

Progress of Th2 cytokines and bronchial asthma pathogenesis

Hu, N., & Wang, H. (2008) · Chinese Journal of Asthma · doi:10.3760/cma.j.issn.1673-436x.2008.19.009

ICAM-1 and VCAM-1 Expression following Aneurysmal Subarachnoid Hemorrhage and Their Possible Role in the Pathophysiology of Subsequent Ischemic Deficits

Rothoerl, R. D., Schebesch, K.-M., Kubitza, M., et al. (2006) · Cerebrovascular Diseases · doi:10.1159/000093243 · Cited by 51 · see citing works